what not to eat on retatrutide How for Best Results & Least Side Effects Retatrutide, an experimental weight-loss drug,

Zhang C

Noskovicova, N., Hinz, B., & Pakshir, P

The standard dosing schedule starts with 0.25 mg weekly for the first four weeks, increases to 0.5 mg weekly from weeks five through eight, and then may escalate to 1 mg or 2 mg weekly depending on tolerance and response

Tirzepatide is no exception, and compounded versions may carry additional considerations compared to the FDA-approved product

Early addition of basal insulin to oral therapy may improve glycemic control, which can reduce the risk of complications

In phase 3 clinical trials, participants using semaglutide (2.4 mg once weekly) showed 10-15% body weight reduction on average after 68 weeks